基于皮佩拉的P2X4受体对手
Katharina Sophie Erlitz1,2, Alena I Siutkina3, Ann-Kathrin Prinz3
1European Institute for Molecular Imaging (EIMI), University of Muenster, Muenster, Germany.
研究人员开发了基于皮佩拉的新型抗剂,向P2X4受体 (P2X4R),这是神经炎症和疼痛的关键参与者. 一些化合物与帕洛克塞丁相比,显示出优越的P2X4R对抗性,表明治疗潜力.
科学领域:
- 神经科学是一个神经科学.
- 药理学 药理学是指药理学的学科.
- 药用化学 医学化学
背景情况:
- P2X4受体 (P2X4R) 与神经炎症,慢性疼痛和癌症有关.
- P2X4R对抗性代表了这些疾病的潜在治疗策略.
- 帕洛西丁作为P2X4R抗体发展的参考化合物.
研究的目的:
- 设计和合成基于皮佩拉的新型P2X4R抗剂.
- 研究这些化合物的结构-活性关系 (SARs).
- 为了识别具有改善P2X4R抗作用力的化合物.
主要方法:
- 合成超过35种基于皮佩拉津的化合物.
- 使用Ca2+-流量试验评估P2X4R对抗活性.
- 吸收,分布,新陈代谢和分泌 (ADME) 属性的评估.
主要成果:
- 几种合成的化合物表现出比帕洛克塞丁更高的P2X4R抗作用力.
- 增加的脂性与高血蛋白结合和降低的代谢稳定性相关.
- 含有纳夫他林-2-氧基组的化合物表现出特殊的代谢负债.
结论:
- 对于基于皮佩拉津的P2X4R抗剂,已经确定了有前途的SAR.
- 需要进一步优化以提高功效和改善药理动力学特性.
- 这项研究为开发针对P2X4R的治疗方法提供了基础.
更多相关视频
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
09:09Preparation and Delivery of Protein Microcrystals in Lipidic Cubic Phase for Serial Femtosecond Crystallography
Published on: September 20, 2016
相关概念视频
Adrenergic Antagonists: Chemistry and Classification of ɑ-Receptor Blockers
Nonselective α-blockers: Nonselective α-blockers contain haloalkylamine or imidazoline...
Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drug-Receptor Interaction: Agonist
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous...
Adrenergic Antagonists: Pharmacological Actions of ɑ-Receptor Blockers
α1-blockers: These drugs inhibit α1-adrenoceptors on smooth muscle cells, resulting in vasodilation. This vasodilation lowers blood pressure, making α1-blockers valuable in treating hypertension. Additionally,...
Antipsychotic Drugs: Typical and Atypical Agents
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
